US STOCKS-Wall St flat as investors await bank earnings
* EMC shares rise after Dell offer
* Lilly sinks after experimental heart drug scrapped
* Indexes down: Dow 0.05 pct, S&P 0.11 pct, Nasdaq 0.02 pct (Updates to open)
By Abhiram Nandakumar
Oct 12 (Reuters) - U.S. stocks were little changed on Monday as investors braced for a busy week of quarterly results from major U.S. banks and several Dow 30 companies.
Health stocks were down after Eli Lilly said it was scrapping an experimental heart drug and taking a related charge in the fourth quarter.
Lilly fell as much as 8.9 percent to $78.47, putting the stock on track for its biggest single-day day decline in seven years. Rival Merck was down 2 percent at $49.91.
On the other hand, Amgen was up 2 percent and Regeneron more than 3 percent. Both companies recently received FDA approval for cholesterol-reducing drugs.
EMC's shares were up 2.6 percent at $28.60 after Dell said it would buy the data storage company in a $67 billion deal. Continuación...